Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 13:20:11 UTC |
---|
Update Date | 2021-09-26 23:07:57 UTC |
---|
HMDB ID | HMDB0254150 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Lofepramine |
---|
Description | Lofepramine belongs to the class of organic compounds known as dibenzazepines. Dibenzazepines are compounds with two benzene rings connected by an azepine ring. Azepine is an unsaturated seven-member heterocycle with one nitrogen atom replacing a carbon atom. Lofepramine is a very strong basic compound (based on its pKa). In humans, lofepramine is involved in imipramine metabolism pathway. This compound has been identified in human blood as reported by (PMID: 31557052 ). Lofepramine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Lofepramine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CN(CCCN1C2=CC=CC=C2CCC2=CC=CC=C12)CC(=O)C1=CC=C(Cl)C=C1 InChI=1S/C26H27ClN2O/c1-28(19-26(30)22-13-15-23(27)16-14-22)17-6-18-29-24-9-4-2-7-20(24)11-12-21-8-3-5-10-25(21)29/h2-5,7-10,13-16H,6,11-12,17-19H2,1H3 |
---|
Synonyms | Value | Source |
---|
1-(4-Chlorophenyl)-2-{[3-(10,11-dihydro-5H-dibenzo[b,F]azepin-5-yl)propyl]methylamino}ethanone | ChEBI | 4'-Chlor-2-((3-(10,11-dihydro-5H-dibenz(b,F)azepin-5-yl)propyl)methylamino)acetophenon | ChEBI | 4'-Chloro-2-((3-(10,11-dihydro-5H-dibenz(b,F)azepin5-yl)propyl)methylamino)acetophenone | ChEBI | Lopramine | ChEBI | Feprapax | MeSH | Ashbourne brand OF lofepramine hydrochloride | MeSH | leo 640 | MeSH | Lomont | MeSH | Gamanil | MeSH | Hydrochloride, lofepramine | MeSH | Merck brand OF lofepramine hydrochloride | MeSH | Rosemont brand OF lofepramine hydrochloride | MeSH | Deftan | MeSH | Lofepramine hydrochloride | MeSH | Gamonil | MeSH |
|
---|
Chemical Formula | C26H27ClN2O |
---|
Average Molecular Weight | 418.97 |
---|
Monoisotopic Molecular Weight | 418.1811912 |
---|
IUPAC Name | 2-[(3-{2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-2-yl}propyl)(methyl)amino]-1-(4-chlorophenyl)ethan-1-one |
---|
Traditional Name | 2-[(3-{2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-2-yl}propyl)(methyl)amino]-1-(4-chlorophenyl)ethanone |
---|
CAS Registry Number | Not Available |
---|
SMILES | CN(CCCN1C2=CC=CC=C2CCC2=CC=CC=C12)CC(=O)C1=CC=C(Cl)C=C1 |
---|
InChI Identifier | InChI=1S/C26H27ClN2O/c1-28(19-26(30)22-13-15-23(27)16-14-22)17-6-18-29-24-9-4-2-7-20(24)11-12-21-8-3-5-10-25(21)29/h2-5,7-10,13-16H,6,11-12,17-19H2,1H3 |
---|
InChI Key | SAPNXPWPAUFAJU-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dibenzazepines. Dibenzazepines are compounds with two benzene rings connected by an azepine ring. Azepine is an unsaturated seven-member heterocycle with one nitrogen atom replacing a carbon atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzazepines |
---|
Sub Class | Dibenzazepines |
---|
Direct Parent | Dibenzazepines |
---|
Alternative Parents | |
---|
Substituents | - Dibenzazepine
- Alkyl-phenylketone
- Alkyldiarylamine
- Phenylketone
- Benzoyl
- Tertiary aliphatic/aromatic amine
- Aryl ketone
- Aryl alkyl ketone
- Azepine
- Chlorobenzene
- Halobenzene
- Aryl halide
- Aryl chloride
- Benzenoid
- Monocyclic benzene moiety
- Alpha-aminoketone
- Tertiary aliphatic amine
- Tertiary amine
- Ketone
- Azacycle
- Hydrocarbon derivative
- Organooxygen compound
- Organic nitrogen compound
- Amine
- Organopnictogen compound
- Organic oxide
- Organic oxygen compound
- Organohalogen compound
- Organochloride
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized | Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Lofepramine GC-MS (Non-derivatized) - 70eV, Positive | splash10-052r-3930000000-7f3233101e9bc3c16ac2 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lofepramine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Lofepramine 35V, Positive-QTOF | splash10-00di-0190000000-939eaff7e4c449d10e95 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lofepramine 10V, Positive-QTOF | splash10-014i-0030900000-f2c1472e308c1b5aef4b | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lofepramine 20V, Positive-QTOF | splash10-00tr-1390200000-e0f7a25f6e2c3cf8cf45 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lofepramine 40V, Positive-QTOF | splash10-0017-7950000000-f7cfdbd1d08c3c9e7b07 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lofepramine 10V, Negative-QTOF | splash10-014i-0100900000-0c66d04816128a1bd142 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lofepramine 20V, Negative-QTOF | splash10-015c-0911400000-f3a351150cd2f078f73a | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lofepramine 40V, Negative-QTOF | splash10-00kf-1900000000-239b62d416a315bf9bef | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lofepramine 10V, Positive-QTOF | splash10-014i-0010900000-417d70665e251f5a9161 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lofepramine 20V, Positive-QTOF | splash10-00yr-3790300000-35b025799d6e47a8cf30 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lofepramine 40V, Positive-QTOF | splash10-000i-2950000000-3b5dd2fb9a45903de9ec | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lofepramine 10V, Negative-QTOF | splash10-014i-0000900000-b75a2d50ee5a83773f68 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lofepramine 20V, Negative-QTOF | splash10-00l6-1970700000-92d67c757a3b7ac10b0e | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lofepramine 40V, Negative-QTOF | splash10-001i-9310100000-31a976888a2df4b86577 | 2021-10-12 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB13411 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | Not Available |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Lofepramine |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 3947 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 47782 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]
|
---|